CLU and multiple system atrophy: Since PD and PDD patients had significantly higher CSF clusterin than patients with atypical parkinsonian disorders (DLB, MSA, and PSP), the potential of this protein as a differential marker has been evaluated using receiver operating characteristic (ROC) curve analysis.